| Schedule of certain unaudited quarterly financial data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, |
|
June 30, |
|
September 30, |
|
December 31, |
|
|
2016 |
|
2016 |
|
2016 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
(in thousands, except per share data) |
Grant revenue |
|
$ |
— |
|
|
$ |
650 |
|
|
$ |
321 |
|
|
$ |
182 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Research and development |
|
2,293 |
|
|
2,502 |
|
|
4,582 |
|
|
773 |
|
General and administrative |
|
2,649 |
|
|
1,636 |
|
|
1,703 |
|
|
1,095 |
|
Change in fair value of warrant liability and unit purchase option liability |
|
(47 |
) |
|
91 |
|
|
(101 |
) |
|
130 |
|
Interest income (expense), net |
|
(151 |
) |
|
(127 |
) |
|
(104 |
) |
|
(83 |
) |
Net loss |
|
$ |
(5,140 |
) |
|
$ |
(3,524 |
) |
|
$ |
(6,169 |
) |
|
$ |
(1,639 |
) |
Net loss per share of common stock, basic and diluted |
|
$ |
(0.59 |
) |
|
$ |
(0.41 |
) |
|
$ |
(0.70 |
) |
|
$ |
(0.18 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, |
|
June 30, |
|
September 30, |
|
December 31, |
|
|
2015 |
|
2015 |
|
2015 |
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
(in thousands, except per share data) |
Operating expenses: |
|
|
|
|
|
|
|
|
Research and development |
|
$ |
1,723 |
|
|
$ |
1,875 |
|
|
$ |
1,238 |
|
|
$ |
1,751 |
|
General and administrative |
|
761 |
|
|
1,016 |
|
|
722 |
|
|
1,924 |
|
Change in fair value of warrant liability, unit purchase option liability and investor rights obligation |
|
(535 |
) |
|
198 |
|
|
1,465 |
|
|
185 |
|
Interest income (expense), net |
|
(219 |
) |
|
(219 |
) |
|
(197 |
) |
|
(158 |
) |
Net loss |
|
$ |
(3,238 |
) |
|
$ |
(2,912 |
) |
|
$ |
(692 |
) |
|
$ |
(3,648 |
) |
Net loss per share of common stock, basic and diluted |
|
$ |
(4.98 |
) |
|
$ |
(4.48 |
) |
|
$ |
(1.06 |
) |
|
$ |
(0.53 |
) |
|